Oliver Moazzezi was working from home when he first heard a loud ringing in his ears. "I had an anxiety attack. I went from ...

PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to ~ Norgine Pharmaceutica ...

ii Infants and young children that are affected by ototoxicity at critical stages of development lack speech and language development and literacy, and older children and adolescents often lack social ...

Mytinnitusnumber.org helps individuals with tinnitus better understand their condition and take proactive steps toward ...

Prescription drugs can be administered in various ways. This includes oral (by mouth), enteral (into the gastrointestinal tract), mucosal (through a mucus membrane), and percutaneous (through the skin ...

The waiver, announced by Secretary of State Marco Rubio, seemed to allow for the distribution of H.I.V. medications, but whether the waiver extended to preventive drugs or other services offered ...

The authors surveyed nearly 350 people about how many attempts it took to quit a substance before they were finally able to maintain their sobriety - revealing which drugs could be the most addicting.

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Three cryo-EM structures of phosphorylated ...

Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine. By Alexandra Stevenson and Zixu Wang Reporting from ...

It’s important to remember that many of these medications only work when you take them along with lifestyle measures, such as a balanced, nutritious diet. If you have high triglyceride levels ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...